Real-time diabetic retinopathy screening by deep learning in a multisite national screening programme: a prospective interventional cohort study
Open accessThe DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Diabetic retinopathy is a leading cause of preventable blindness, especially in low-income and middle-income countries (LMICs). Deep-learning systems have the potential to enhance diabetic retinopathy screenings in these settings, yet prospective studies assessing their usability and performance are scarce. METHODS: We did a prospective interventional cohort study to evaluate the real-world performance and feasibility of deploying a deep-learning system into the health-care system of Thailand. Patients with diabetes and listed on the national diabetes registry, aged 18 years or older, able to have their fundus photograph taken for at least one eye, and due for screening as per the Thai Ministry of Public Health guidelines were eligible for inclusion. Eligible patients were screened with the deep-learning system at nine primary care sites under Thailand's national diabetic retinopathy screening programme. Patients with a previous diagnosis of diabetic macular oedema, severe non-proliferative diabetic retinopathy, or proliferative diabetic retinopathy; previous laser treatment of the retina or retinal surgery; other non-diabetic retinopathy eye disease requiring referral to an ophthalmologist; or inability to have fundus photograph taken of both eyes for any reason were excluded. Deep-learning system-based interpretations of patient fundus images and referral recommendations were provided in real time. As a safety mechanism, regional retina specialists over-read each image. Performance of the deep-learning system (accuracy, sensitivity, specificity, positive predictive value [PPV], and negative predictive value [NPV]) were measured against an adjudicated reference standard, provided by fellowship-trained retina specialists. This study is registered with the Thai national clinical trials registry, TCRT20190902002. FINDINGS: Between Dec 12, 2018, and March 29, 2020, 7940 patients were screened for inclusion. 7651 (96·3%) patients were eligible for study analysis, and 2412 (31·5%) patients were referred for diabetic retinopathy, diabetic macular oedema, ungradable images, or low visual acuity. For vision-threatening diabetic retinopathy, the deep-learning system had an accuracy of 94·7% (95% CI 93·0-96·2), sensitivity of 91·4% (87·1-95·0), and specificity of 95·4% (94·1-96·7). The retina specialist over-readers had an accuracy of 93·5 (91·7-95·0; p=0·17), a sensitivity of 84·8% (79·4-90·0; p=0·024), and specificity of 95·5% (94·1-96·7; p=0·98). The PPV for the deep-learning system was 79·2 (95% CI 73·8-84·3) compared with 75·6 (69·8-81·1) for the over-readers. The NPV for the deep-learning system was 95·5 (92·8-97·9) compared with 92·4 (89·3-95·5) for the over-readers. INTERPRETATION: A deep-learning system can deliver real-time diabetic retinopathy detection capability similar to retina specialists in community-based screening settings. Socioenvironmental factors and workflows must be taken into consideration when implementing a deep-learning system within a large-scale screening programme in LMICs. FUNDING: Google and Rajavithi Hospital, Bangkok, Thailand. TRANSLATION: For the Thai translation of the abstract see Supplementary Materials section.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Autonomous point-of-care, centralized AI or teleophthalmology, and hybrid AI-plus-human grading models should not be ranked universally, because each offers a different balance of immediacy, specialist oversight, infrastructure requirements, and workflow complexity.”
From From validation to public health impact: implementing equitable AI-enabled diabetic retinopathy screening (2026) · cites this paper as [11]
In the citing paper
“Real-time national deployment in Thailand and African clinical validation studies further show that AI performance depends on workflow, image acquisition, and the surrounding screening pathway (9,11).”
From From validation to public health impact: implementing equitable AI-enabled diabetic retinopathy screening (2026) · cites this paper as [11]
In the citing paper
“Autonomous systems can provide same-visit results and reduce dependence on asynchronous grading, whereas centralized models may support multisite quality assurance and specialist oversight; hybrid models retain human review for selected or uncertain cases (8,10,11,14,17,21).”
From From validation to public health impact: implementing equitable AI-enabled diabetic retinopathy screening (2026) · cites this paper as [11]
In the citing paper
“Artificial intelligence (AI) is an accurate screening tool for diabetic retinopathy (DR), the leading cause of blindness among working-aged adults.”
From Referral uptake after diabetic retinopathy screening with artificial intelligence-assisted care pathways: a systematic review and meta-analysis (2026) · cites this paper as [6]
In the citing paper
“Multiple artificial intelligence (AI) algorithms have been developed and validated for DR5–8 screening and it is the most frequently implemented deep learning application in prospective real-world studies9.”
From Referral uptake after diabetic retinopathy screening with artificial intelligence-assisted care pathways: a systematic review and meta-analysis (2026) · cites this paper as [6]
Citations
Cites
Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., Colagiuri, S., Guariguata, L., Motala, A. A., Ogurtsova, K., et al. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107843 · Cited by 10,792
Gulshan, V., Peng, L., Coram, M., Stumpe, M. C., Wu, D., Narayanaswamy, A., Venugopalan, S., Widner, K., Madams, T., Cuadros, J., et al. (2016) · JAMA · doi:10.1001/jama.2016.17216 · Cited by 7,697
Self-citationWilkinson, C. P., Ferris, F. L., Klein, R. E., Lee, P. P., Agardh, C. D., Davis, M., Dills, D., Kampik, A., Pararajasegaram, R., & Verdaguer, J. T. (2003) · Ophthalmology · doi:10.1016/s0161-6420(03)00475-5 · Cited by 3,743
Ting, D. S. W., Cheung, C. Y.-L., Lim, G., Tan, G. S. W., Quang, N. D., Gan, A., Hamzah, H., Garcia-Franco, R., San Yeo, I. Y., Lee, S. Y., et al. (2017) · JAMA · doi:10.1001/jama.2017.18152 · Cited by 2,402
Abràmoff, M. D., Lavin, P. T., Birch, M., Shah, N., & Folk, J. C. (2018) · npj Digital Medicine · doi:10.1038/s41746-018-0040-6 · Cited by 1,638
Guidelines on Diabetic Eye Care
Wong, T. Y., Sun, J., Kawasaki, R., Ruamviboonsuk, P., Gupta, N., Lansingh, V. C., Maia, M., Mathenge, W., Moreker, S., Muqit, M. M. K., et al. (2018) · Ophthalmology · doi:10.1016/j.ophtha.2018.04.007 · Cited by 839
Self-citationBeede, E., Baylor, E., Hersch, F., Iurchenko, A., Wilcox, L., Ruamviboonsuk, P., & Vardoulakis, L. M. (2020) · Proceedings of the 2020 CHI Conference on Human Factors in Computing Systems · doi:10.1145/3313831.3376718 · Cited by 614
Self-citationKrause, J., Gulshan, V., Rahimy, E., Karth, P., Widner, K., Corrado, G. S., Peng, L., & Webster, D. R. (2018) · Ophthalmology · doi:10.1016/j.ophtha.2018.01.034 · Cited by 564
Self-citationLiu, X., Cruz Rivera, S., Moher, D., Calvert, M. J., Denniston, A. K., Ashrafian, H., Beam, A. L., Chan, A.-W., Collins, G. S., Deeks, A. D. J., et al. (2020) · The Lancet Digital Health · doi:10.1016/s2589-7500(20)30218-1 · Cited by 555
Mansournia, M. A., & Altman, D. G. (2016) · BMJ · doi:10.1136/bmj.i189 · Cited by 433
Research works printed but not linked: 1
- Saritsiri, 2021, Comparative study of 1- year health outcome related smoking among diabetes patients in primary care, Bangkok, Thailand, Tob Induc Dis, 19, A210
Cited by
Ciecierski-Holmes, T., Singh, R., Axt, M., Brenner, S., & Barteit, S. (2022) · npj Digital Medicine · doi:10.1038/s41746-022-00700-y · Cited by 343
Integrated image-based deep learning and language models for primary diabetes care
Li, J., Guan, Z., Wang, J., Cheung, C. Y., Zheng, Y., Lim, L.-L., Lim, C. C., Ruamviboonsuk, P., Raman, R., Corsino, L., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03139-8 · Cited by 250
Self-citationWenderott, K., Krups, J., Zaruchas, F., & Weigl, M. (2024) · npj Digital Medicine · doi:10.1038/s41746-024-01248-9 · Cited by 199
Machine learning in precision diabetes care and cardiovascular risk prediction
Oikonomou, E. K., & Khera, R. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01985-3 · Cited by 190
Rajesh, A. E., Davidson, O. Q., Lee, C. S., & Lee, A. Y. (2023) · Diabetes Care · doi:10.2337/dci23-0032 · Cited by 150
Metadata
- Authors
- Ruamviboonsuk, P., Tiwari, R., Sayres, R., Nganthavee, V., Hemarat, K., Kongprayoon, A., Raman, R., Levinstein, B., Liu, Y., Schaekermann, M., Lee, R., Virmani, S., Widner, K., Chambers, J., Hersch, F., Peng, L., & Webster, D. R.
- Affiliations
- Rajavithi Hospital (TH)
- Google (United States) (US)
- Vajira Hospital (TH)
- Nakornping Hospital (TH)
- Sankara Nethralaya (IN)
- Noom (United States) (US)
- Amazon (United States) (US)
- Imperial College London (GB)
- Corresponding author
- Sayres, Rory
- Venue
- The Lancet Digital Health
- Publisher
- Elsevier BV
- Published
- 2022-04
- Volume
- 4
- Issue
- 4
- Pages
- e235-e244
- ISSN
- 2589-7500 (ISSN-L)
- OpenAlex
- W4220926288
- Cited by
- 250
- References
- 32
- Citations by year
- 2026: 59 · 2025: 60 · 2024: 60 · 2023: 57 · 2022: 13
- FWCI
- 27.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Locations
- The Lancet Digital Health (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Google Inc
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Ophthalmology and Visual Health Research
- Keywords
- diabetic retinopathy screening, deep learning, fundus images, diabetic macular edema, primary care, national screening program, low- and middle-income countries, Thailand, diagnostic accuracy, referral guidelines, field deployment, avoidable blindness, diabetes complications
- MeSH terms
- Deep Learning, Diabetes Mellitus, Diabetic Retinopathy, Humans, Macular Edema, Prospective Studies, Thailand, Cohort Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Real-time diabetic retinopathy screening by deep learning in a multisite national screening programme: a prospective interventional cohort study. https://app.cochat.ai/papers/10.1016/s2589-7500(22)00017-6
- The paper
- Ruamviboonsuk, P., Tiwari, R., Sayres, R., Nganthavee, V., Hemarat, K., Kongprayoon, A., Raman, R., Levinstein, B., Liu, Y., Schaekermann, M., Lee, R., Virmani, S., Widner, K., Chambers, J., Hersch, F., Peng, L., & Webster, D. R. (2022). Real-time diabetic retinopathy screening by deep learning in a multisite national screening programme: a prospective interventional cohort study. The Lancet Digital Health. https://doi.org/10.1016/s2589-7500(22)00017-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.